<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Elevated plasma <z:chebi fb="0" ids="17230">homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) concentrations are associated with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Several recent reports have indicated that <z:chebi fb="3" ids="15765">L-dopa</z:chebi> treatment is an acquired cause of hyperhomo-cysteinemia </plain></SENT>
<SENT sid="2" pm="."><plain>Despite the fact that a large proportion of <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) patients develop <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunctions</z:e> or <z:hpo ids='HP_0000726'>dementia</z:hpo>, particularly in the late stages of the illness and after long-term <z:chebi fb="3" ids="15765">L-dopa</z:chebi> treatment, the relationship between <z:chebi fb="0" ids="17230">Hcy</z:chebi> and <z:hpo ids='HP_0000726'>dementia</z:hpo> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> has not been fully investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to evaluate plasma <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels in a group of <z:chebi fb="3" ids="15765">L-dopa</z:chebi>-treated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and to elucidate a possible role of <z:chebi fb="0" ids="17230">Hcy</z:chebi> in the development of <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunctions</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We compared <z:chebi fb="0" ids="17230">Hcy</z:chebi>, <z:chebi fb="9" ids="17439">vitamin B12</z:chebi> and <z:chebi fb="3" ids="37445">folate</z:chebi> levels in 35 parkinsonian patients treated with <z:chebi fb="3" ids="15765">L-dopa</z:chebi> (14 with <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunctions</z:e>, 21 without <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>) </plain></SENT>
<SENT sid="5" pm="."><plain>Analysis of the data revealed that mean <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels were significantly higher in the group with <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunctions</z:e> (21.2+/-7.4 vs. 15.8+/-4.4 micromol/L; p=0.0001), while there was no difference in age, sex, <z:chebi fb="13" ids="33611">B12</z:chebi> and <z:chebi fb="3" ids="37445">folate</z:chebi> levels </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, logistic regression analysis showed that the risk of <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunction</z:e> progressively increased according to <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels after correction for age, sex and B-vitamin status (odds ratio, 19.1; 95% CI, 1.5-241.4; p=0.02) </plain></SENT>
<SENT sid="7" pm="."><plain>Our results raise the possibility of a relationship between <z:chebi fb="0" ids="17230">Hcy</z:chebi> levels and <z:e sem="disease" ids="C0338656" disease_type="Mental or Behavioral Dysfunction" abbrv="">cognitive dysfunctions</z:e> in this group of <z:chebi fb="3" ids="15765">L-dopa</z:chebi>-treated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>However, prospective studies on large cohorts of patients should be performed to clarify such an association </plain></SENT>
</text></document>